Artemisinin-based combinations
暂无分享,去创建一个
[1] Arjen Dondorp,et al. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial , 2005, The Lancet.
[2] F. Nosten,et al. A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy. , 2005, The Journal of infectious diseases.
[3] F. Nosten,et al. A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] U. d’Alessandro,et al. Antimalarial efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, and the combinations of amodiaquine + artesunate and sulfadoxine-pyrimethamine + artesunate in Huambo and Bie provinces, central Angola. , 2005, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[5] Angus Cameron,et al. A single amino acid residue can determine the sensitivity of SERCAs to artemisinins , 2005, Nature Structural &Molecular Biology.
[6] Z. Premji,et al. Efficacy and safety of artemether-lumefantrine (Coartem) tablets (six-dose regimen) in African infants and children with acute, uncomplicated falciparum malaria. , 2005, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[7] R. Hallett,et al. Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial , 2005, The Lancet.
[8] F. Checchi,et al. Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial , 2005, The Lancet.
[9] S. Toovey. Reply to comment on: Audiometric changes associated with the treatment of uncomplicated falciparum malaria with co-artemether , 2005 .
[10] D. Durrheim,et al. Comment on: Audiometric changes associated with the treatment of uncomplicated falciparum malaria with co-artemether. , 2005, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[11] C. Hughson,et al. Comment on: Audiometric changes associated with the treatment of uncomplicated falciparum malaria with co-artemether. , 2005, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[12] M. Msellem,et al. In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem). , 2005, The Journal of infectious diseases.
[13] S. Hay,et al. The global distribution of clinical episodes of Plasmodium falciparum malaria , 2005, Nature.
[14] F. Checchi,et al. Efficacy of two artemisinin combination therapies for uncomplicated falciparum malaria in children under 5 years, Malakal, Upper Nile, Sudan , 2005, Malaria Journal.
[15] J. Tumwine,et al. Rectal artemether versus intravenous quinine for the treatment of cerebral malaria in children in Uganda: randomised clinical trial , 2005, BMJ : British Medical Journal.
[16] J. Guthmann,et al. Efficacy and effectiveness of the combination of sulfadoxine/pyrimethamine and a 3‐day course of artesunate for the treatment of uncomplicated falciparum malaria in a refugee settlement in Zambia , 2005, Tropical medicine & international health : TM & IH.
[17] S. P. Kachur,et al. Adherence to antimalarial combination therapy with sulfadoxine-pyrimethamine and artesunate in rural Tanzania. , 2004, The American journal of tropical medicine and hygiene.
[18] M. Mayxay,et al. Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross‐sectional survey on the prevalence of fake antimalarials , 2004, Tropical medicine & international health : TM & IH.
[19] Grant Dorsey,et al. Combination treatments for uncomplicated falciparum malaria in Kampala, Uganda: randomised clinical trial , 2004, The Lancet.
[20] A. Attaran. Rescuing malaria treatment, or not? , 2004, The Lancet.
[21] F. Nosten,et al. Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand. , 2004, The Journal of infectious diseases.
[22] N. White,et al. Comparative Pharmacokinetics of Intramuscular Artesunate and Artemether in Patients with Severe Falciparum Malaria , 2004, Antimicrobial Agents and Chemotherapy.
[23] T. Jelínek,et al. Therapeutic efficacy of artemether‐lumefantrine and artesunate‐mefloquine for treatment of uncomplicated Plasmodium falciparum malaria in Luang Namtha Province, Lao People's Democratic Republic , 2004, Tropical medicine & international health : TM & IH.
[24] F. Checchi,et al. Adherence to a six-dose regimen of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Uganda. , 2004, The American journal of tropical medicine and hygiene.
[25] R. Price,et al. In Vivo Assessment of Drug Efficacy against Plasmodium falciparum Malaria: Duration of Follow-Up , 2004, Antimicrobial Agents and Chemotherapy.
[26] P. Newton,et al. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[27] J. Guthmann,et al. Adherence to a combination of artemether and lumefantrine (Coartem®) in Kajo Keji, southern Sudan , 2004, Annals of tropical medicine and parasitology.
[28] K. Barnes,et al. Artemisinin‐based combination therapy reduces expenditure on malaria treatment in KwaZulu Natal, South Africa , 2004, Tropical medicine & international health : TM & IH.
[29] I. Adam,et al. Artemether in the treatment of falciparum malaria during pregnancy in eastern Sudan. , 2004, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[30] P. Shetty. Global fund switches to artemisinin. , 2004, The Lancet. Infectious diseases.
[31] Paolo Vicini,et al. Disposition of Artesunate and Dihydroartemisinin after Administration of Artesunate Suppositories in Children from Papua New Guinea with Uncomplicated Malaria , 2004, Antimicrobial Agents and Chemotherapy.
[32] R. Price,et al. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number , 2004, The Lancet.
[33] Yuxiang Dong,et al. Synthetic peroxides as antimalarials , 2004, Medicinal research reviews.
[34] S. Toovey,et al. Audiometric changes associated with the treatment of uncomplicated falciparum malaria with co-artemether. , 2004, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[35] M. Galinski,et al. WHO, the Global Fund, and medical malpractice in malaria treatment , 2004, The Lancet.
[36] L. Aarons,et al. Population pharmacokinetics of artemether and dihydroartemisinin following single intramuscular dosing of artemether in African children with severe falciparum malaria. , 2003, British journal of clinical pharmacology.
[37] S. Krishna,et al. Artemisinins target the SERCA of Plasmodium falciparum , 2003, Nature.
[38] P. Olliaro,et al. A meta-analysis using individual patient data of trials comparing artemether with quinine in the treatment of severe falciparum malaria. , 2001, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[39] B. Lowe,et al. The disposition of intramuscular artemether in children with cerebral malaria; a preliminary study. , 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.